Posts in tag

PPIs


Pharmacists are well placed to spot swallowing trouble early and to help manage the problem as part of a health care team, write Carlene McMaugh and Jarrod McMaugh Pharmacists will …

Debbie Rigby rounds up the latest in research news  Oral Anticoagulants and Proton Pump Inhibitor Cotherapy Among patients initiating oral anticoagulant treatment, incidence of hospitalization for upper gastrointestinal tract bleeding …

New research has found a link between use of proton pump inhibitors and iron deficiency A collaboration between academics at the Universities of Melbourne, Utrecht and Maastricht is the first …

Debbie Rigby rounds up the latest in research news  Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults In a large cohort of older adults in primary care, …

Debbie Rigby takes a look at the latest in research news Diagnosis and management of Parkinson’s disease in adults In July 2017, NICE updated its 2006 guideline on Parkinson’s disease …

Debbie Rigby rounds up the latest in research news Fall-Risk-Increasing Drugs Use of certain medications is recognized as a major and modifiable risk factor for falls. In this systematic review …

Debbie Rigby takes a look at the latest in research news  Development of a clinical pharmacy model within an Australian home nursing service This paper describes a collaborative, person-centred model …

Debbie Rigby takes a look around at the latest in research news  Effect of vitamin D supplementation on non-skeletal disorders This systematic review explored more recently published meta-analyses and randomised …

ASMI has issued a statement saying consumers can be confident in the safety profile of OTC proton pump inhibitors A study published in Gut has shown that people who regularly …

Debbie Rigby takes a look at the latest in research news  We have had a gutful: The need for deprescribing proton pump inhibitors Times series analysis of PBS and RPBS …

The Schedule 3 entry for proton-pump inhibitor esomeprazole is set to be deleted from 1 February 2018 The TGA delegate has made an interim decision to downschedule the PPI to Pharmacy …

Debbie Rigby takes a look at the latest in research news Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL …